1
|
Anti-Inflammatory Activity of Cnidoscolus aconitifolius (Mill.) Ethyl Acetate Extract on Croton Oil-Induced Mouse Ear Edema. APPLIED SCIENCES-BASEL 2021. [DOI: 10.3390/app11209697] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Nowadays, there is a growing interest in the development of medicinal plant-based therapies to diminish the ravages of the inflammatory process related to diseases and tissue damage. Most therapeutic effects of these traditional medicinal plants are owed to their phenolic and antioxidant properties. C. aconitifolius is a traditional medicinal plant in Mexico. Previous characterization reports have stated its high nutritional and antioxidant components. The present study aimed to better understand the biological activity of C. aconitifolius in inflammation response. We developed an ethyl acetate extract of this plant to evaluate its anti-inflammatory capacity and its flavonoid content. The topical anti-inflammatory effect of the ethyl acetate extract of C. aconitifolius was determined by the croton oil-induced mouse ear edema test, while flavonoid detection and concentration were determined by thin layer chromatography and the aluminum chloride colorimetric assay, respectively. Topical application of the extract showed significant inhibition of the induced-ear edema (23.52 and 49.41% for 25 and 50 mg/kg dose, respectively). The extract also exhibited the presence of flavonoids. The finding of the anti-inflammatory activity exerted by the C. aconitifolius and the identification of its active principles may suggest and support its use for inflammation treatment.
Collapse
|
2
|
El tratamiento de las verrugas con guarumbo por los zapotecos. ACTAS DERMO-SIFILIOGRAFICAS 2020; 111:189-191. [DOI: 10.1016/j.ad.2018.10.013] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2018] [Revised: 10/23/2018] [Accepted: 10/28/2018] [Indexed: 11/17/2022] Open
|
3
|
Fernandez-Flores A, Llamas Velasco M, Saeb Lima M. Guarumbo (Cecropia obtusifolia) for Warts in Zapotec Medicine. ACTAS DERMO-SIFILIOGRAFICAS 2020. [DOI: 10.1016/j.adengl.2018.10.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
4
|
Amaral-Machado L, Oliveira WN, Moreira-Oliveira SS, Pereira DT, Alencar ÉN, Tsapis N, Egito EST. Use of Natural Products in Asthma Treatment. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE : ECAM 2020; 2020:1021258. [PMID: 32104188 PMCID: PMC7040422 DOI: 10.1155/2020/1021258] [Citation(s) in RCA: 26] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/10/2019] [Revised: 12/31/2019] [Accepted: 01/06/2020] [Indexed: 12/14/2022]
Abstract
Asthma, a disease classified as a chronic inflammatory disorder induced by airway inflammation, is triggered by a genetic predisposition or antigen sensitization. Drugs currently used as therapies present disadvantages such as high cost and side effects, which compromise the treatment compliance. Alternatively, traditional medicine has reported the use of natural products as alternative or complementary treatment. The aim of this review was to summarize the knowledge reported in the literature about the use of natural products for asthma treatment. The search strategy included scientific studies published between January 2006 and December 2017, using the keywords "asthma," "treatment," and "natural products." The inclusion criteria were as follows: (i) studies that aimed at elucidating the antiasthmatic activity of natural-based compounds or extracts using laboratory experiments (in vitro and/or in vivo); and (ii) studies that suggested the use of natural products in asthma treatment by elucidation of its chemical composition. Studies that (i) did not report experimental data and (ii) manuscripts in languages other than English were excluded. Based on the findings from the literature search, aspects related to asthma physiopathology, epidemiology, and conventional treatment were discussed. Then, several studies reporting the effectiveness of natural products in the asthma treatment were presented, highlighting plants as the main source. Moreover, natural products from animals and microorganisms were also discussed and their high potential in the antiasthmatic therapy was emphasized. This review highlighted the importance of natural products as an alternative and/or complementary treatment source for asthma treatment, since they present reduced side effects and comparable effectiveness as the drugs currently used on treatment protocols.
Collapse
Affiliation(s)
- Lucas Amaral-Machado
- Graduate Program in Health Sciences, Dispersed System Laboratory (LaSid), Pharmacy Department, Federal University of Rio Grande do Norte (UFRN), Av. General Gustavo de Cordeiro-SN-Petrópolis, Natal 59012-570, Brazil
- Institut Galien Paris-Sud, CNRS, Univ. Paris-Sud, Université Paris-Saclay, 92296 Châtenay-Malabry, France
| | - Wógenes N. Oliveira
- Graduate Program in Health Sciences, Dispersed System Laboratory (LaSid), Pharmacy Department, Federal University of Rio Grande do Norte (UFRN), Av. General Gustavo de Cordeiro-SN-Petrópolis, Natal 59012-570, Brazil
| | - Susiane S. Moreira-Oliveira
- Graduate Program in Health Sciences, Dispersed System Laboratory (LaSid), Pharmacy Department, Federal University of Rio Grande do Norte (UFRN), Av. General Gustavo de Cordeiro-SN-Petrópolis, Natal 59012-570, Brazil
| | - Daniel T. Pereira
- Graduate Program in Health Sciences, Dispersed System Laboratory (LaSid), Pharmacy Department, Federal University of Rio Grande do Norte (UFRN), Av. General Gustavo de Cordeiro-SN-Petrópolis, Natal 59012-570, Brazil
| | - Éverton N. Alencar
- Graduate Program in Pharmaceutical Nanotechnology, LaSid, UFRN, Av. General Gustavo de Cordeiro-SN-Petropolis, Natal 59012-570, Brazil
| | - Nicolas Tsapis
- Institut Galien Paris-Sud, CNRS, Univ. Paris-Sud, Université Paris-Saclay, 92296 Châtenay-Malabry, France
| | - Eryvaldo Sócrates T. Egito
- Graduate Program in Health Sciences, Dispersed System Laboratory (LaSid), Pharmacy Department, Federal University of Rio Grande do Norte (UFRN), Av. General Gustavo de Cordeiro-SN-Petrópolis, Natal 59012-570, Brazil
- Graduate Program in Pharmaceutical Nanotechnology, LaSid, UFRN, Av. General Gustavo de Cordeiro-SN-Petropolis, Natal 59012-570, Brazil
| |
Collapse
|
5
|
Ferreira FS, Brito SV, Coutinho HDM, Souza EP, Almeida WO, Alves RRN. Vertebrates as a Bactericidal Agent. ECOHEALTH 2018; 15:619-626. [PMID: 29922961 DOI: 10.1007/s10393-018-1345-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/11/2016] [Revised: 05/15/2018] [Accepted: 05/16/2018] [Indexed: 06/08/2023]
Abstract
In Brazil, although a large number of animals are used in traditional medicine (at least 354 species), information about their biological activities is scarce. In this context, the objective of this study was to evaluate the bactericidal potential of zootherapeutic by-products from animals used in Brazilian traditional medicine and discuss the ecological and cultural consequences of such practices. The species analyzed were: Tupinambis merianae (skin), Iguana iguana (skin and body fat), Crotalus durissus (skin and body fat), Boa constrictor (skin), Euphractus sexcinctus (body fat) and Coendou prehensilis (quills). Experiments were performed with standard clinical strains of Escherichia coli (EC-ATCC10536) and Staphylococcus aureus (SA-ATCC 25923). For the microbiological assay, the zootherapeutics were evaluated using serial microdilutions. The results indicate that none of the samples possess inhibitory activity against standard bacterial strains. The in vitro ineffectiveness of the analyzed products demonstrate a necessity for new pharmacological research that encompass a large number of species of medicinal animals as well as highlight the importance of zootherapy in the context of plans for animal conservation.
Collapse
Affiliation(s)
- F S Ferreira
- Universidade Federal do Vale do São Francisco, Colegiado Acadêmico de Ecologia, Senhor do Bonfim, BA, Brazil.
| | - S V Brito
- Universidade Federal do Maranhão, Centro de Ciências Agrárias e Ambientais, Chapadinha, MA, Brazil
| | - H D M Coutinho
- Departamento de Química Biológica, Universidade Regional do Cariri, Crato, CE, Brazil
| | - E P Souza
- Departamento de Morfologia, Universidade Federal do Ceará, Fortaleza, CE, Brazil
| | - W O Almeida
- Departamento de Química Biológica, Universidade Regional do Cariri, Crato, CE, Brazil
| | - R R N Alves
- Departamento de Biologia, Universidade Estadual da Paraíba, Campina Grande, PB, Brazil
| |
Collapse
|
6
|
Abstract
Human health and animal health are closely intertwined. We share hundreds of diseases with animals, and they are vectors for many diseases that assail humans—but, at the same time, they are essential to many treatments and cures. We discuss in this chapter various aspects of intimate relationship between human and animal health, giving examples of the importance of multidisciplinary studies in understanding these connections and the fundamental aspects of strategies for promoting the health and well-being of both groups.
Collapse
|
7
|
Marino-Marmolejo EN, Flores-Hernández FY, Flores-Valdez MA, García-Morales LF, González-Villegas AC, Bravo-Madrigal J. A quantitative model for dermal infection and oedema in BALB/c mice pinna. BMC Microbiol 2016; 16:290. [PMID: 27955621 PMCID: PMC5151133 DOI: 10.1186/s12866-016-0907-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2016] [Accepted: 12/02/2016] [Indexed: 12/31/2022] Open
Abstract
Background Pharmaceutical industry demands innovation for developing new molecules to improve effectiveness and safety of therapeutic medicines. Preclinical assays are the first tests performed to evaluate new therapeutic molecules using animal models. Currently, there are several models for evaluation of treatments, for dermal oedema or infection. However, the most common or usual way is to induce the inflammation with chemical substances instead of infectious agents. On the other hand, this kind of models require the implementation of histological techniques and the interpretation of pathologies to verify the effectiveness of the therapy under assessment. This work was focused on developing a quantitative model of infection and oedema in mouse pinna. The infection was achieved with a strain of Streptococcus pyogenes that was inoculated in an injury induced at the auricle of BALB/c mice, the induced oedema was recorded by measuring the ear thickness with a digital micrometer and histopathological analysis was performed to verify the damage. The presence of S. pyogenes at the infection site was determined every day by culture. Results Our results showed that S. pyogenes can infect the mouse pinna and that it can be recovered at least for up to 4 days from the infected site; we also found that S. pyogenes can induce a bigger oedema than the PBS-treated control for at least 7 days; our results were validated with an antibacterial and anti-inflammatory formulation made with ciprofloxacin and hydrocortisone. Conclusions The model we developed led us to emulate a dermal infection and allowed us to objectively evaluate the increase or decrease of the oedema by measuring the thickness of the ear pinna, and to determine the presence of the pathogen in the infection site. We consider that the model could be useful for assessment of new anti-inflammatory or antibacterial therapies for dermal infections.
Collapse
Affiliation(s)
- Erika Nahomy Marino-Marmolejo
- Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco A.C. Biotecnología Médica y Farmacéutica, Av. Normalistas No. 800. Colinas de la Normal, C. P. 44270, Guadalajara, Jalisco, México
| | - Flor Yohana Flores-Hernández
- Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco A.C. Biotecnología Médica y Farmacéutica, Av. Normalistas No. 800. Colinas de la Normal, C. P. 44270, Guadalajara, Jalisco, México
| | - Mario Alberto Flores-Valdez
- Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco A.C. Biotecnología Médica y Farmacéutica, Av. Normalistas No. 800. Colinas de la Normal, C. P. 44270, Guadalajara, Jalisco, México
| | - Luis Felipe García-Morales
- Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco A.C. Biotecnología Médica y Farmacéutica, Av. Normalistas No. 800. Colinas de la Normal, C. P. 44270, Guadalajara, Jalisco, México
| | - Ana Cecilia González-Villegas
- OPKO México, Pharmacos Exakta S.A. de C.V. Laboratorio de Investigación y Desarrollo, Av. Niño Obrero No. 651. Chapalita Sur, C. P. 45040, Zapopan, Jalisco, México
| | - Jorge Bravo-Madrigal
- Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco A.C. Biotecnología Médica y Farmacéutica, Av. Normalistas No. 800. Colinas de la Normal, C. P. 44270, Guadalajara, Jalisco, México.
| |
Collapse
|
8
|
Noufou O, Anne-Emmanuelle H, Claude W OJ, Richard SW, André T, Marius L, Jean-Baptiste N, Jean K, Marie-Genevieve DF, Pierre GI. BIOLOGICAL AND PHYTOCHEMICAL INVESTIGATIONS OF EXTRACTS FROM PTEROCARPUS ERINACEUS POIR (FABACEAE) ROOT BARKS. AFRICAN JOURNAL OF TRADITIONAL, COMPLEMENTARY, AND ALTERNATIVE MEDICINES 2016; 14:187-195. [PMID: 28480397 PMCID: PMC5411871 DOI: 10.21010/ajtcam.v14i1.21] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Background: Pterocarpus erinaceus Poir. belonging to Fabacae familly is used as medicinal plant in Burkina Faso’s folk medicine. Roots of P. erinaceus are used to treat ulcer, stomach ache and inflammatory diseases. The objective of the present study was to carry out phytochemical composition of methanol (MeOH) and dichloromethane (DCM) extracts from Pterocarpus erinaceus roots, to isolate pure compounds, and to evaluate their pharmacological activities. Methods: Chromatographic fractionation led to the isolation of active components of the extracts. The structures were established by NMR analysis and comparison with data from literature. The anti-inflammatory activity was evaluated using croton oil-induced edema of mice ear as well as the effect of extracts against lipoxygenase and lipid peroxidation was evaluated. 2,2-diphenyl-1-picrylhydrazyl (DPPH) and Cupric-reducing antioxidant capacity (CUPRAC) methods were used to evaluate the antioxidant activity of the extracts. Results: Friedelin (1), 3a-hydroxyfriedelan-2-one (2), a-sophoradiol (3) and stigmasterol (4) were isolated from DCM extract and maltol-6-O-apiofuranoside-glucopyranoside (5) isolated from MeOH. DCM extract and friedelin, 3a-hydroxyfriedelan-2-one, a-sophoradiol showed a significant anti-inflammatory effect against ear edema. Friedelin (1), α-sophoradiol (3) and maltol-6-O-apiofuranoside-glucopyranoside (5) exhibited lipoxygenase inhibition. MeOH extract (100 μg/mL) inhibited lipoxygenase and lipid peroxidation activities at 45.1 ± 3% and 30.7 ± 0.5% respectively. MeOH extract, ethyl acetate fraction and butanol fraction exhibited antioxidant property with both two methods used. Conclusion: The results suggested that the extracts and compounds from roots of Pterocarpus erinaceus possessed local anti-inflammatory effect, antioxidant properties and inhibitor effect against lipoxygenase and lipid peroxidation activities.
Collapse
Affiliation(s)
- Ouédraogo Noufou
- Département de médecine-pharmacopée traditionnelle/pharmacie (IRSS/CNRST) 03 BP 7192 Ouagadougou 03, Burkina Faso.,Laboratoire de développement du médicament, UFR/SDS, Université de Ouagadougou 03 BP 7021 Ouagadougou 03, Burkina Faso.,UMR 5557 CNRS-Université Lyon 1, Ecologie Microbienne, Villeurbanne, F-69622, France
| | - Hay Anne-Emmanuelle
- UMR 5557 CNRS-Université Lyon 1, Ecologie Microbienne, Villeurbanne, F-69622, France
| | - Ouédraogo Jean Claude W
- Département de médecine-pharmacopée traditionnelle/pharmacie (IRSS/CNRST) 03 BP 7192 Ouagadougou 03, Burkina Faso
| | - Sawadogo W Richard
- Département de médecine-pharmacopée traditionnelle/pharmacie (IRSS/CNRST) 03 BP 7192 Ouagadougou 03, Burkina Faso
| | - Tibiri André
- Département de médecine-pharmacopée traditionnelle/pharmacie (IRSS/CNRST) 03 BP 7192 Ouagadougou 03, Burkina Faso
| | - Lompo Marius
- Département de médecine-pharmacopée traditionnelle/pharmacie (IRSS/CNRST) 03 BP 7192 Ouagadougou 03, Burkina Faso
| | - Nikiema Jean-Baptiste
- Laboratoire de développement du médicament, UFR/SDS, Université de Ouagadougou 03 BP 7021 Ouagadougou 03, Burkina Faso
| | - Koudou Jean
- Laboratoire de développement du médicament, UFR/SDS, Université de Ouagadougou 03 BP 7021 Ouagadougou 03, Burkina Faso
| | | | - Guissou Innocent Pierre
- Département de médecine-pharmacopée traditionnelle/pharmacie (IRSS/CNRST) 03 BP 7192 Ouagadougou 03, Burkina Faso.,Laboratoire de développement du médicament, UFR/SDS, Université de Ouagadougou 03 BP 7021 Ouagadougou 03, Burkina Faso
| |
Collapse
|